Pricing Log in Create free account

Telomir Pharmaceuticals, Inc. (TELO) vs Xilio Therapeutics, Inc. (XLO)

Telomir Pharmaceuticals, Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. Telomir Pharmaceuticals, Inc. and Xilio Therapeutics, Inc. are of similar size ($57.5M and $55.9M). Telomir Pharmaceuticals, Inc. has the higher net margin (0.00% vs −34.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Telomir Pharmaceuticals, Inc. leads on 6 and Xilio Therapeutics, Inc. on 6.

Valuation

Metric TELO XLO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 2.61 9.40
P/B 8.82 2.32 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 0.51 9.02
Earnings yield (124.66%) (17.27%) (32.88%)
Free cash flow yield (11.07%) (36.59%) (23.13%)

Profitability

Metric TELO XLO Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% (48.94%) 0.00%
Net margin 0.00% (34.06%) 0.00%
Free cash flow margin 0.00% (95.59%) 0.00%
Return on equity (1,885.50%) (55.03%) (51.96%)
Return on assets (1,678.31%) (15.16%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TELO XLO Biotechnology median
Revenue growth (TTM) — 327.25% 6.76%
EPS growth (last fiscal year) 41.07% 72.55% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric TELO XLO Biotechnology median
Debt to equity 0.03 0.00 0.00
Current ratio 16.14 4.25 4.97
Net debt to EBITDA 0.69 3.40 1.01

Dividend

Metric TELO XLO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric TELO XLO Biotechnology median
Market cap 57.48m 55.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack